NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)
Funding Amount
Not stated
Deadline
May 25, 2029
919 days left
Grant Type
Federal
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Tribal governments
- State governments
- Private colleges & universities
- Public & Indian housing authorities
- Public colleges & universities
- For-profit businesses
- Tribal organizations
- Nonprofits (501(c)(3))
Overview
NIAID Investigator Initiated Program Project Applications
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by continuing support for investigator-initiated Program Project applications. The program encourages applications for investigator-initiated program projects proposed in scientific areas relevant to the NIAID mission including the biology, pathogenesis, and host response to microbes; mechanisms regulating immune system development and function across the lifespan, and/or in response to infectious pathogens; immune dysfunction resulting in autoimmunity, immunodeficiency, allergy, asthma, or transplant rejection; and translational research to develop vaccines, therapeutics, and diagnostics to prevent and treat infectious, immune-mediated, and allergic diseases. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.
Details
- Agency: National Institutes of Health
- Department: Department of Health and Human Services
- Opportunity #: FOR-AI-27-008
- Instrument: grant
Focus Areas & Funding Uses
Fields of Work
- Science research
- Healthcare
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
National Institutes of Health
Amount
Varies
Deadline
November 19, 2026
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
National Institutes of Health
Amount
Varies
Deadline
November 19, 2026
HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
National Institutes of Health
Amount
Up to $375,000
Deadline
November 23, 2026
Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)
National Institutes of Health
Amount
$3,400,000 total
Deadline
November 23, 2026
Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$6,000,000 total
Deadline
November 23, 2026
Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed)
National Institutes of Health
Amount
$3,500,000 total
Deadline
November 23, 2026
Ready to apply for NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed). Now let's win it.